• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞、冲击波和富含血小板的血浆疗法治疗勃起功能障碍和 Peyronie 病:对美国各地诊所的调查。

Stem-Cell, Shockwave, and Platelet Rich Plasma Therapy for the Treatment of Erectile Dysfunction and Peyronie's Disease: A Survey of Clinics Across the USA.

机构信息

Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL.

Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL.

出版信息

Urology. 2023 Aug;178:83-90. doi: 10.1016/j.urology.2023.01.061. Epub 2023 Apr 17.

DOI:10.1016/j.urology.2023.01.061
PMID:37076023
Abstract

OBJECTIVE

To identify clinics offering off-label therapies for erectile dysfunction (ED) and Peyronie's disease (Pyd) including stem cell, platelet-rich plasma (PRP), and shockwave therapy and to determine the transparency they provided to patients inquiring about these treatment modalities.

METHODS

Clinics were identified in different regions in the US using a systematic search on online website directories and were approached by asking a series of standardized questions regarding the cost of treatment, duration of therapy, the medical staff involved, and patient outcome data. A total of 26 clinics were surveyed for stem cell therapy, 26 for PRP treatment, and 27 for shockwave therapy.

RESULTS

Of the 79 clinics contacted, 93.7% provided some answers to the questions we asked, with a majority offering treatments for both ED and Pyd. The cost of treatment varied widely between clinics. The average cost per stem cell therapy injection was $5291, PRP per injection was $1336, and shockwave therapy per session was $413. A physician was involved in 67% of treatments, and only 6 of 79 clinics reported that a urologist was involved. Over 75% of the clinics reported patient satisfaction following treatment. Durability of benefits to patients ranged from months to years according to the clinics' reports.

CONCLUSION

Our data not only demonstrate the widespread use of off-label therapies for ED and PyD across the United States but also the lack of scientific data to support the claims made to patients. This study highlights the need for more oversight and standardization in novel regenerative therapies for ED and PyD.

摘要

目的

确定提供非标签治疗勃起功能障碍(ED)和 Peyronie 病(Pyd)的诊所,包括干细胞、富含血小板的血浆(PRP)和冲击波治疗,并确定它们向询问这些治疗方式的患者提供的透明度。

方法

使用系统搜索在线网站目录在美国不同地区确定诊所,并通过询问一系列关于治疗费用、治疗持续时间、参与的医务人员以及患者结果数据的标准化问题来接近这些诊所。共调查了 26 家干细胞治疗诊所、26 家 PRP 治疗诊所和 27 家冲击波治疗诊所。

结果

在所联系的 79 家诊所中,93.7%对我们提出的问题提供了一些答案,其中大多数提供 ED 和 Pyd 的治疗。治疗费用在诊所之间差异很大。每个干细胞治疗注射的平均费用为 5291 美元,PRP 每次注射的费用为 1336 美元,冲击波治疗每次疗程的费用为 413 美元。67%的治疗涉及医生,只有 79 家诊所中的 6 家报告泌尿科医生参与。超过 75%的诊所报告称,患者在治疗后感到满意。根据诊所的报告,患者受益的持久性从几个月到几年不等。

结论

我们的数据不仅表明美国广泛使用非标签治疗 ED 和 PyD,而且缺乏支持向患者提出的主张的科学数据。本研究强调需要对 ED 和 PyD 的新型再生治疗进行更多的监督和标准化。

相似文献

1
Stem-Cell, Shockwave, and Platelet Rich Plasma Therapy for the Treatment of Erectile Dysfunction and Peyronie's Disease: A Survey of Clinics Across the USA.干细胞、冲击波和富含血小板的血浆疗法治疗勃起功能障碍和 Peyronie 病:对美国各地诊所的调查。
Urology. 2023 Aug;178:83-90. doi: 10.1016/j.urology.2023.01.061. Epub 2023 Apr 17.
2
Platelet-Rich Plasma Therapy for Male Sexual Dysfunction: Myth or Reality?富血小板血浆疗法治疗男性性功能障碍:是神话还是现实?
Sex Med Rev. 2020 Jan;8(1):106-113. doi: 10.1016/j.sxmr.2019.02.002. Epub 2019 Mar 19.
3
Platelet-Rich Plasma Injections for Erectile Dysfunction and Peyronie's Disease: A Systematic Review of Evidence.富血小板血浆注射治疗勃起功能障碍和佩罗尼氏病:证据的系统评价
Sex Med Rev. 2022 Apr;10(2):341-352. doi: 10.1016/j.sxmr.2020.12.004. Epub 2021 Jul 2.
4
Platelet-rich plasma therapy in erectile dysfunction and Peyronie's disease: a systematic review of the literature.富血小板血浆疗法治疗勃起功能障碍和 Peyronie 病:文献系统评价。
World J Urol. 2024 May 29;42(1):359. doi: 10.1007/s00345-024-05065-3.
5
[Biotherapies for erectile dysfunction and Peyronie's disease: Where are we now?].[勃起功能障碍和佩罗尼氏病的生物疗法:我们目前的进展如何?]
Prog Urol. 2020 Dec;30(16):1000-1013. doi: 10.1016/j.purol.2020.05.002. Epub 2020 Aug 18.
6
[Extracorporeal shockwave therapy for erectile dysfunction and Peyronie's disease].[体外冲击波疗法治疗勃起功能障碍和佩罗尼氏病]
Zhonghua Nan Ke Xue. 2014 Sep;20(9):846-9.
7
Shockwave Therapy in the Treatment of Peyronie's Disease.冲击波疗法治疗 Peyronie 病。
Sex Med Rev. 2019 Jul;7(3):499-507. doi: 10.1016/j.sxmr.2019.02.001. Epub 2019 Mar 26.
8
An overview of the Canadian landscape on the use of restorative therapies for erectile dysfunction and Peyronie's disease.加拿大使用恢复性疗法治疗勃起功能障碍和佩罗尼氏病的情况概述。
Can Urol Assoc J. 2024 Dec;18(12):420-424. doi: 10.5489/cuaj.8804.
9
Review of the Current Status of Low Intensity Extracorporeal Shockwave Therapy (Li-ESWT) in Erectile Dysfunction (ED), Peyronie's Disease (PD), and Sexual Rehabilitation After Radical Prostatectomy With Special Focus on Technical Aspects of the Different Marketed ESWT Devices Including Personal Experiences in 350 Patients.低强度体外冲击波疗法(Li-ESWT)在勃起功能障碍(ED)、佩罗尼氏病(PD)及前列腺癌根治术后性康复中的现状综述,特别关注不同市售ESWT设备的技术方面,包括350例患者的个人经验
Sex Med Rev. 2021 Jan;9(1):93-122. doi: 10.1016/j.sxmr.2020.01.006. Epub 2020 Jun 2.
10
A primer on the restorative therapies for erectile dysfunction: a narrative review.关于勃起功能障碍的修复治疗:一篇叙述性综述。
Sex Med Rev. 2024 Jun 26;12(3):505-512. doi: 10.1093/sxmrev/qeae012.

引用本文的文献

1
Incorporating regenerative therapies in the management of erectile dysfunction and Peyronie's disease.将再生疗法纳入勃起功能障碍和佩罗尼氏病的治疗中。
Int J Impot Res. 2025 Sep 10. doi: 10.1038/s41443-025-01168-6.
2
Efficacy of low-intensity pulsed ultrasound (LIPUS) in the treatment of erectile dysfunction: a systematic review.低强度脉冲超声(LIPUS)治疗勃起功能障碍的疗效:一项系统评价
Int Urol Nephrol. 2025 Jun 30. doi: 10.1007/s11255-025-04639-3.
3
Rising public interest in stem cell therapy for erectile dysfunction: an analysis of public perception and a review of the literature.
公众对干细胞治疗勃起功能障碍的兴趣日益增加:公众认知分析与文献综述
Ther Adv Urol. 2025 Feb 24;17:17562872251322651. doi: 10.1177/17562872251322651. eCollection 2025 Jan-Dec.
4
Treatment with Autologous Adipose-derived Regenerative Cells for Peyronie's Disease in Men: The Straight @head Pilot Study.男性佩罗尼氏病的自体脂肪源性再生细胞治疗:STRAIGHT@HEAD初步研究。
Eur Urol Open Sci. 2024 Dec 31;71:180-186. doi: 10.1016/j.euros.2024.12.005. eCollection 2025 Jan.
5
An update on the use of stem cell therapy for erectile dysfunction.干细胞疗法治疗勃起功能障碍的最新进展。
Asian J Urol. 2024 Oct;11(4):530-544. doi: 10.1016/j.ajur.2023.07.005. Epub 2024 Mar 11.
6
Evidence of restorative therapies in the treatment of Peyronie disease: A narrative review.在 Peyronie 病治疗中修复疗法的证据:叙事性综述。
Int Braz J Urol. 2024 Nov-Dec;50(6):703-713. doi: 10.1590/S1677-5538.IBJU.2024.9920.
7
Search traffic for inflatable penile prosthesis increased following the COVID-19 pandemic in the United States: a Google Trends analysis.美国新冠疫情期间可膨胀阴茎假体的搜索量增加:谷歌趋势分析
Int J Impot Res. 2025 May;37(5):361-365. doi: 10.1038/s41443-024-00922-6. Epub 2024 May 30.